Archive: 11/11/2011

Results of the ADVISE trial reported at TCT 2011

Researchers conducting the ADVISE clinical trial have concluded that a new measure of stenosis severity, instantaneous wave-free ratio (iFR), yielded similar results to traditional fractional flow reserve (FFR) without the ...

Nov 11, 2011
popularity 4 / 5 (1) | comments 0

Results of the TWENTE trial reported at TCT 2011

The TWENTE clinical trial, which compared two second generation drug-eluting stents – zotarolimus and everolimus-eluting stents – established non-inferiority between the two stents as measured by the primary endpoint: ...

Nov 11, 2011
popularity not rated yet | comments 0

Results of the COBRA trial reported at TCT 2011

A clinical trial of patients with diabetes has demonstrated that cryoplasty post-dilitation compared to conventional balloon angioplasty in the superficial femoral artery (SFA) decreased the risk of in-stent restenosis (ISR). ...

Nov 11, 2011
popularity not rated yet | comments 0

Results of the REMEDEE trial reported at TCT 2011

A randomized comparison of a dual therapy stent – which combines low-dose sirolimus delivery from an abluminal biodegradable polymer matrix with a covalently bound anti-CD34 antibody layer – with a paclitaxel-eluting ...

Nov 11, 2011
popularity not rated yet | comments 0

Results of the ROTAXUS trial reported at TCT 2011

A clinical trial testing the efficacy of rotational atherectomy (or rotablation, a process of drilling through plaque deposits) prior to implantation of a drug-eluting stent found that the process was not superior to standard ...

Nov 11, 2011
popularity not rated yet | comments 0

Results of the EVOLVE trial reported at TCT 2011

A clinical trial has established the non-inferiority of a drug-eluting stent with a bioabsorbable polymer compared to a drug-eluting stent with a durable polymer. Results of the EVOLVE clinical trial were presented today ...

Nov 11, 2011
popularity not rated yet | comments 0

Stronger flu shots, more side effects

Ordinary flu vaccine has always worked out for Carolyn Hendrickson, so the 77-year-old was perplexed on a recent Monday when her clinic gave her a high-dose version without asking first.

Nov 11, 2011
popularity not rated yet | comments 0